In addition, GILZ expression has been described in myeloma99, lymphoblastic leukemia, and chronic myeloid leukemia (CML)100, suggesting that GILZ has a role in the pharmacological GC-mediated apoptosis of myelodysplastic disorders. This evidence concerns the gene TSC22D3 and chronic myelogenous leukemia, BCR-ABL1 positive.